Fertility Protective Effect of Taxifolin in Cisplatin-Induced Ovarian Damage

dc.contributor.author Ozyurt, R.
dc.contributor.author Celik, N.
dc.contributor.author Suleyman, Z.
dc.contributor.author Cagiran, F.
dc.contributor.author Kali, Z.
dc.contributor.author Gurkan, N.
dc.contributor.author Suleyman, H.
dc.date.accessioned 2025-05-10T16:54:17Z
dc.date.available 2025-05-10T16:54:17Z
dc.date.issued 2022
dc.description.abstract OBJECTIVE: The aim of our study was to investigate the protective effect of taxifolin on ovarian damage and reproductive dysfunction created by cisplatin administration. MATERIALS AND METHODS: A total of 36 albino Wistar female adult rats were equally divided into 3 groups as cisplatin administered only (CIS), taxifolin+cisplatin (T+C) and healthy control group (HG). Taxifolin 50 mg/kg was administered orally by gavage in the T+C (n=12) group. In the HG (n=12) and CIS (n=12) groups, the same volume of distilled water as a solvent was orally administered. One hour after administration of taxifolin or distilled water, animals in the T+C and CIS groups were injected with cisplatin at a dose of 2.5 mg/kg intraperitoneally. This procedure was repeated once a day for 14 days. Six animals from each group were sacrificed on day 15, and their ovaries were removed for histopathological and biochemical analysis. Ovarian tissue malondialdehyde (MDA), total Glutathione (tGSH), Nuclear Factor-Kappa B (NF-kB), Tumor Necrosis Factor-α (TNF-α), Interleukin 1 beta (IL-1β), and Interleukin-6 (IL-6) levels were measured. The remaining animals (n=6 in each group) were kept in the laboratory with mature male rats for two months to breed. RESULTS: CIS administration led to an increase in inflammatory molecules and membrane lipid peroxidation products, and decreased the synthesis of antioxidant molecules. Compared to the CIS group, the ovarian tissue MDA, NF-kB, TNF-α, IL-1β and IL-6 levels were found to be significantly decreased in the T+C group (p<0.001 for all comparisons). On the other hand, the tGSH levels of the T+C group were significantly higher than the CIS group (p<0.001). Milder ovarian necrosis, fibrosis and follicle damage were detected in animals which were given taxifolin. Four out of the six rats (67%) treated with taxifolin gave birth within 27 days. CONCLUSIONS: We demonstrated, for the first time, that taxifolin ameliorates cisplatin-induced ovarian injury by decreasing MDA and proinflammatory cytokines and increasing the antioxidant enzyme. The fact that more than half of the animals receiving taxifolin became pregnant suggests that the cytoprotective effect of taxifolin is strong enough to preserve fertility. © 2022 Verduci Editore s.r.l. All rights reserved. en_US
dc.identifier.doi 10.26355/eurrev_202210_29909
dc.identifier.issn 1128-3602
dc.identifier.scopus 2-s2.0-85140217740
dc.identifier.uri https://doi.org/10.26355/eurrev_202210_29909
dc.identifier.uri https://hdl.handle.net/20.500.14720/3078
dc.language.iso en en_US
dc.publisher Verduci Editore s.r.l en_US
dc.relation.ispartof European Review for Medical and Pharmacological Sciences en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Anti-Inflammatory en_US
dc.subject Antioxidant en_US
dc.subject Cisplatin en_US
dc.subject Ovarian Injury en_US
dc.subject Taxifolin en_US
dc.title Fertility Protective Effect of Taxifolin in Cisplatin-Induced Ovarian Damage en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Gurkan, Naziye/0000-0003-1088-018X
gdc.author.id Ozyurt, Ramazan/0000-0001-6822-2222
gdc.author.scopusid 8428967200
gdc.author.scopusid 10439050500
gdc.author.scopusid 56523253700
gdc.author.scopusid 37041169600
gdc.author.scopusid 46461526700
gdc.author.scopusid 55297177100
gdc.author.scopusid 57213672050
gdc.author.wosid Di̇nc, Kemal/Glu-7744-2022
gdc.author.wosid Gurkan, Naziye/Jcf-2534-2023
gdc.author.wosid Ozyurt, Ramazan/Jqw-7276-2023
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp Ozyurt R., Istanbul Center for Assisted Reproduction and Gynecology, Istanbul, Turkey; Celik N., Department of Biochemistry, Behcet Uz Children's Hospital, Izmir, Turkey; Suleyman Z., Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey; Cagiran F., Department of Obstetrics and Gynecology, Genesis Hospital, Diyarbakir, Turkey; Kali Z., Department of Obstetrics and Gynecology, Gözde Private Hospital, Malatya, Turkey; Gurkan N., Department of Obstetrics and Gynecology, Medicalpark Hospital, Samsun, Turkey; Altindag F., Department of Histology and Embryology, Faculty of Medicine, Van Yüzüncü Yil University, Van, Turkey; Bulut S., Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey; Sarigul C., Department of Biochemistry, Faculty of Medicine, Ataturk University, Erzurum, Turkey; Dinc K., Department of Obstetrics and Gynecology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey; Suleyman H., Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey en_US
gdc.description.endpage 7203 en_US
gdc.description.issue 19 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 7195 en_US
gdc.description.volume 26 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 36263529
gdc.identifier.pmid 36263529
gdc.identifier.wos WOS:000877188200039
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files